Skip to main content

Advertisement

Log in

Mortality and complications 1 year after treatment of hydrocephalus with endoscopic third ventriculostomy and ventriculoperitoneal shunt in children at Queen Elizabeth Central Hospital, Malawi

  • Original Article - CSF Circulation
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Background

Over the past two decades, the management of hydrocephalus has witnessed the addition of endoscopic third ventriculostomy with or without choroid plexus cauterization (ETV ± CPC) to the traditional methods including ventriculoperitoneal shunt insertion (VPSI). We conducted this study to assess mortality and complications with surgical implications associated with the two procedures in children with hydrocephalus.

Methods

We reviewed our operating theater registry to identify children below 17 years old who underwent hydrocephalus surgery for the first time in 2016. The patients were followed for up to 1 year from the date of the initial operation. Their vital status was confirmed by follow-up visits by a community nurse. Descriptive analyses were used to describe the characteristics of the patients and evaluate the study outcomes (i.e., mortality and complications).

Results

One hundred fifty-three patients were eligible for the study; 56% were males and 73.2% had primary ETV ± CPC. Complete 1-year follow-up data was available for 79 patients, and 73.4% of these had ETV ± CPC. One-year success (event-free) rates for ETV and VPSI were similar at 67.4% and 66.7%, respectively. ETVs in infants under 6 months performed poorly; failing in half the infants, who were subsequently converted to VPS. Shunt sepsis was very high, 21.4% (95% CI 10.3–36.8). The majority of surgical complications (81.8%) occurred within 3 months of surgery.

Conclusion

ETV ± CPC and VPSI carry a similar frequency of mortality and complications in our setting, and therefore, both should be considered as a treatment option for patients with hydrocephalus. As VP shunt is still used for managing most of the patients, there is still a need to prioritize measures to reduce shunt infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CPC:

Choroid plexus cauterization

CSF:

Cerebrospinal fluid

EVD:

External ventricular drain

ETV:

Endoscopic third ventriculostomy

IQR:

Inter-quartile range

VPSI:

Ventriculoperitoneal shunt insertion

References

  1. Aschoff A, Kremer P, Hashemi B (1999) The scientific history of hydrocephalus and its treatment. Neurosurg Rev 22:67–933

    Article  CAS  Google Scholar 

  2. Burton A (2017) Training non-physicians as neurosurgeons in sub-Saharan Africa. Lancet Neurol 16(9):684–685

    Article  Google Scholar 

  3. Dewan MC, Rattani A, Mekary R, Glancz LJ, Yunusa I, Baticulon RE et al (2018) Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis. J Neurosurg 130(4):1065–1079

    Article  Google Scholar 

  4. Forte D, Peraio S, Huttunen TJ, James G, Thompson D, Aquilina K (2021) Ventriculo-atrial and ventriculo-pleural shunts as second-line surgical treatment have equivalent revision, infection, and survival rates in paediatric hydrocephalus. Childs Nerv Syst 37(2):481–489

    Article  Google Scholar 

  5. Fritsch MJ, Kienke S, Ankermann T, Padoin M, Mehdorn HM (2005) Endoscopic third ventriculostomy in infants. J Neurosurg Pediatr 103(1):50–53

    Article  Google Scholar 

  6. Gilard V, Chadie A, Ferracci FX, Brasseur-Daudruy M, Proust F, Marret S et al (2018) Post hemorrhagic hydrocephalus and neurodevelopmental outcomes in a context of neonatal intraventricular hemorrhage: an institutional experience in 122 preterm children. BMC Pediatr 18(1):1–8

    Article  Google Scholar 

  7. Hagerty V, Galvin C, Maharaj A, Vrionis F (2022) Ventriculo-atrial shunts as an alternate therapy in patients with normal pressure hydrocephalus refractory to ventriculoperitoneal shunts: a case series. Interdiscip Neurosurg 27:101433. https://doi.org/10.1016/j.inat.2021.101433

    Article  Google Scholar 

  8. He Z, An C, Zhang X, He X, Li Q (2015) The efficacy analysis of endoscopic third ventriculostomy in infantile hydrocephalus. J Korean Neurosurg Soc 57(2):119

    Article  CAS  Google Scholar 

  9. Idowu O, Olumide A (2011) Etiology and cranial CT scan profile of nontumoral hydrocephalus in a tertiary black African hospital. Neurosurg Pediatr 7:397–400. https://doi.org/10.3171/2011.1.PEDS10481

    Article  Google Scholar 

  10. Jallo GI, Kothbauer KF, Abbott IR (2005) Endoscopic third ventriculostomy. Neurosurgery. Focus 19(6):E11

    Google Scholar 

  11. Javadpour M, Mallucci C, Brodbelt A, Golash A, May P (2001) The impact of endoscopic third ventriculostomy on the management of newly diagnosed hydrocephalus in infants. Pediatr Neurosurg 35(3):131–135

    Article  CAS  Google Scholar 

  12. Kamalo P (2013) Point of view: exit ventriculoperitoneal shunt; enter endoscopic third ventriculostomy (ETV): contemporary views on hydrocephalus and their implications on management. Malawi Med J 25(September):78–82

    CAS  Google Scholar 

  13. Khan F, Shamim MS, Rehman A, Bari ME (2013) Analysis of factors affecting ventriculoperitoneal shunt survival in pediatric patients. Childs Nerv Syst 29:791–802. https://doi.org/10.1007/s00381-012-2004-5

    Article  Google Scholar 

  14. Koch D, Wagner W (2004) Endoscopic third ventriculostomy in infants of less than 1 year of age: which factors influence the outcome? Child’s Nerv Syst 20:405–411

    Article  Google Scholar 

  15. Kulkarni AV, Schiff SJ, Mbabazi-Kabachelor E, Mugamba J, Ssenyonga P, Donnelly R et al (2017) Endoscopic treatment versus shunting for infant hydrocephalus in Uganda. N Engl J Med 377(25):2456–2524

    Article  Google Scholar 

  16. Laeke T, Tirsit A, Biluts H, Murali D, Wester K (2017) Pediatric hydrocephalus in Ethiopia: treatment failures and infections: a hospital-based, retrospective study. World Neurosurg 100:30–37. https://doi.org/10.1016/j.wneu.2016.12.112

    Article  Google Scholar 

  17. Lepard JR, Dewan MC, Chen SH, Bankole OB, Mugamba J, Ssenyonga P et al (2020) The CURE Protocol: evaluation and external validation of a new public health strategy for treating paediatric hydrocephalus in low-resource settings. BMJ Glob Health 5:e002100. https://doi.org/10.1136/bmjgh-2019-002100

    Article  Google Scholar 

  18. Limbrick DD, Baird LC, Klimo P, Riva-Cambrin J, Flannery AM (2014) Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 4: cerebrospinal fluid shunt or endoscopic third ventriculostomy for the treatment of hydrocephalus in children. J Neurosurg: Pediatr 14(Supplement_1):30–4

    Google Scholar 

  19. Massimi L, Paternoster G, Fasano T, Rocco C (2009) On the changing epidemiology of hydrocephalus. Childs Nerv Syst 25:795–800

    Article  Google Scholar 

  20. McGirt MJ, Zaas A, Fuchs HE, George TM, Kaye K, Sexton DJ (2003) Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 36(7):858–862

    Article  Google Scholar 

  21. Niu H, Wu H, Luo W, Wang K, Zhao L, Wang Y (2021) Ventriculoatrial shunt as a feasible regimen for certain patients of hydrocephalus: clinical features and surgical management. Acta Neurol Belg 121(2):403–408

    Article  Google Scholar 

  22. Oliveras LM, Ortega JL, Leidinger A, Haji MA, Genovés MP, Belloch JP (2020) Infant hydrocephalus in sub-Saharan Africa: impact of perioperative care in the Zanzibar archipelago. Neurocirugía (English Edition) 31(5):223–30

    Article  Google Scholar 

  23. Reid T, Grudziak J, Rodriguez-Ormaza N, Maine RG, Msiska N, Quinsey C et al (2019) Complications and 3-month outcomes of children with hydrocephalus treated with ventriculoperitoneal shunts in Malawi. J Neurosurg Pediatr 24:120–127. https://doi.org/10.3171/2019.2.peds18325

    Article  Google Scholar 

  24. Riva-Cambrin J, Kestle JR, Holubkov R, Butler J, Kulkarni AV, Drake J et al (2016) Risk factors for shunt malfunction in pediatric hydrocephalus: a multicenter prospective cohort study. J Neurosurg Pediatr 17(4):382–390

    Article  Google Scholar 

  25. Robertson FC, Esene IN, Kolias AG, Khan T, Rosseau G, Gormley WB et al (2020) Global perspectives on task shifting and task sharing in neurosurgery. World Neurosurg X 6:100060. https://doi.org/10.1016/j.wnsx.2019.100060

    Article  Google Scholar 

  26. Rush J, Paľa A, Kapapa T, Mayer B, Micah-Bonongwe A, Kamalo P et al (2021) Assessing neurodevelopmental outcome in children with hydrocephalus in Malawi. A pilot study. Clin Neurol Neurosurg 212:107091. https://doi.org/10.1016/j.clineuro.2021.107091

    Article  Google Scholar 

  27. Rutala WA, Weber DJ (2001) New disinfection and sterilization methods. Emerg Infect Dis 7(2):348–353

    Article  CAS  Google Scholar 

  28. Salvador SF, Henriques JC, Munguambe M, Vaz RC, Barros HP (2014) Hydrocephalus in children less than 1 year of age in northern Mozambique. Surg Neurol Int 5:175

    Article  Google Scholar 

  29. Schwartz TH, Ho B, Prestigiacomo CJ, Bruce JN, Feldstein NA, Goodman RR (1999) Ventricular volume after third ventriculostomy. J Neurosurg 91(20–25):0728572201

    Google Scholar 

  30. Sobana M, Halim D, Aviani JK, Gamayani U, Achmad TH (2021) Neurodevelopmental outcomes after ventriculoperitoneal shunt placement in children with non-infectious hydrocephalus: a meta-analysis. Childs Nerv Syst 37(4):1055–1065

    Article  Google Scholar 

  31. Spector R, Keep RF, Snodgrass SR, Smith QR, Johanson CE (2015) A balanced view of choroid plexus structure and function: focus on adult humans. Exp Neurol 1(267):78–86

    Article  Google Scholar 

  32. Thompson D (2005) Hydrocephalus and shunts. In: Moore AJ, Newell DW (eds) Neurosurgery Principles and Practice. Springer, London, pp p425-442

    Chapter  Google Scholar 

  33. Uche EO, Onyia E, Mezue UC, Okorie E, Ozor II, Chikani MC (2013) Determinants and outcomes of ventriculoperitoneal shunt infections in Enugu. Nigeria Pediatric Neurosurg 49(2):75–80. https://doi.org/10.1159/000357384

    Article  CAS  Google Scholar 

  34. Waluza J, Borgstein E (2005) Management of hydrocephalus using the Chabbra shunt. Malawi Med J 17:7–8. https://doi.org/10.4314/mmj.v17i1.10861

    Article  CAS  Google Scholar 

  35. Warf B, Ondoma S, Kulkarni A, Donnelly R, Ampeire M, Akona J et al (2009) Neurocognitive outcome and ventricular volume in children with myelomeningocele treated for hydrocephalus in Uganda. J Neurosurg Pediatr 4:564–570

    Article  Google Scholar 

  36. Warf BC (2010) Pediatric hydrocephalus in East Africa: prevalence, causes, treatments, and strategies for the future. World Neurosurg 73(4):296–300

    Article  Google Scholar 

  37. Weil AG, Westwick H, Wang S, Alotaibi NM, Elkaim L, Ibrahim GM et al (2016) Efficacy and safety of endoscopic third ventriculostomy and choroid plexus cauterization for infantile hydrocephalus: a systematic review and meta-analysis. Childs Nerv Syst 32(11):2119–2131

    Article  Google Scholar 

Download references

Acknowledgements

We acknowledge Favour Kaunda for her assistance through the community nursing service and Linda Kalirani-Phiri for her assistance with (language) editing and proofreading.

Author information

Authors and Affiliations

Authors

Contributions

CM—research conception, literature review, data collection, data analysis, manuscript preparation, and approval of the final draft

HC—data analysis, first draft preparation and literature review, editing of further drafts, and approval of the final draft

PK—research conception, data analysis, manuscript preparation, editing of all drafts, and preparation of the final draft

The authors read and approved the final manuscript.

Corresponding author

Correspondence to C. Hara.

Ethics declarations

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors

Research involving human participants and/or animals

None

Informed consent

No informed consent

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on CSF Circulation

Appendix

Appendix

Table 1

Table 1 One-year epidemiology, management, and causes of hydrocephalus

Table 2

Table 2 One-year mortality and surgical morbidity profiles of children aged 16 years and below, treated for hydrocephalus with endoscopic third ventriculostomy and ventriculoperitoneal shunts

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chimaliro, S., Hara, C. & Kamalo, P. Mortality and complications 1 year after treatment of hydrocephalus with endoscopic third ventriculostomy and ventriculoperitoneal shunt in children at Queen Elizabeth Central Hospital, Malawi. Acta Neurochir 165, 61–69 (2023). https://doi.org/10.1007/s00701-022-05392-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-022-05392-7

Keywords

Navigation